FDA Grants AP Status for SUN PHARM's Ganirelix Acetate Supplement
The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for SUN PHARM's supplement of Ganirelix Acetate.
Therapeutic Area
Therapeutic area intelligence for Reproductive Health with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.